Skip to main
SBRA

SBRA Stock Forecast & Price Target

SBRA Analyst Ratings

Based on 8 analyst ratings
Hold
Strong Buy 0%
Buy 38%
Hold 63%
Sell 0%
Strong Sell 0%

Bulls say

Sabra Health Care REIT Inc demonstrates a positive outlook due to notable improvements in occupancy and rent coverage, which strengthen its operational performance. Additionally, the anticipated recovery of the seniors housing managed portfolio is expected to enhance Sabra’s leverage position, allowing the company to pursue growth opportunities effectively. Furthermore, the healthcare real estate sector's favorable demand drivers and Sabra's above-average exposure to RIDEA create a solid foundation for future growth and value generation.

Bears say

The financial outlook for Sabra Health Care REIT is hampered by uncertainties surrounding operator performance, particularly amid a challenging inflationary environment that affects rental payments. Additionally, compared to its peers, the company is not as low-levered and is currently trading near the upper end of its historical valuation range, limiting potential for earnings growth from acquisitions. The elevated cost of equity further diminishes prospects for immediate earnings accretion, raising concerns about its competitive positioning within the healthcare REIT sector.

SBRA has been analyzed by 8 analysts, with a consensus rating of Hold. 0% of analysts recommend a Strong Buy, 38% recommend Buy, 63% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Sabra Health Care and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Sabra Health Care (SBRA) Forecast

Analysts have given SBRA a Hold based on their latest research and market trends.

According to 8 analysts, SBRA has a Hold consensus rating as of Feb 4, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $20.75, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $20.75, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Sabra Health Care (SBRA)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.